Henan Genuine Biotech Co., Ltd.

This study tests two oral drugs, GEN-725 and Dositinib, together in people with advanced non-small cell lung cancer that has a specific EGFR mutation. The trial has two phases: first to find safe doses, then to see if the combination shrinks tumors. About 110 participants will ta…

This study is testing an experimental drug called CL-197 in 24 adults with HIV-1 who have never taken any anti-HIV drugs. The goal is to see if a single dose can lower the amount of virus in the blood and to check for side effects. Participants will be monitored for about two wee…

This early-stage study tests a new tablet called GEN-725 in 48 adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety, how the body processes it, and whether it can shrink tumors. Participants must be b…

This study tests a new oral drug called dositinib in people with advanced non-small cell lung cancer that has a specific EGFR mutation. The trial has two parts: first, finding the safest dose, then testing that dose in a larger group. Researchers will monitor side effects, how th…